TUTEVA
Dead / Abandoned — Abandoned — after publication (as of 28 Sept 2022)
What this means for you
This application is over — abandoned 28 Sept 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90563235
- Mark type
- Stylized text
- Filed
- 05 Mar 2021
- Published for opposition
- 02 Nov 2021
- Abandoned
- 28 Sept 2022
- Attorney of record
- Brian J. Focarino
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes
- Class 010 — Medical apparatus: Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients
- Class 042 — Scientific and technological services: Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis
- Class 044 — Medical, beauty and agricultural services: Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients
Owner
- Verici Dx Plc, Cardiff, GB
- Verici Dx Plc, Cardiff, GB
Prosecution history
- 28 Sept 2022 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 28 Sept 2022 — ABANDONMENT - AFTER PUBLICATION
- 28 Sept 2022 — TEAS EXPRESS ABANDONMENT RECEIVED
- 26 Apr 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Mar 2022 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 17 Nov 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Nov 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 17 Nov 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Nov 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Nov 2021 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 02 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Nov 2021 — PUBLISHED FOR OPPOSITION
- 13 Oct 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Sept 2021 — ASSIGNED TO EXAMINER